发明授权
US08962268B2 Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)
有权
确定患有非小细胞肺癌（NSCLC）患者生存预后的方法
- 专利标题： Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)
- 专利标题（中）： 确定患有非小细胞肺癌（NSCLC）患者生存预后的方法
-
申请号： US13138849申请日： 2010-04-12
-
公开(公告)号： US08962268B2公开(公告)日： 2015-02-24
- 发明人: Richard De Wijn , Robby Ruijtenbeek , Maria Helena Hilhorst
- 申请人： Richard De Wijn , Robby Ruijtenbeek , Maria Helena Hilhorst
- 申请人地址： NL 's-Hertogenbosch
- 专利权人： Pamgene B.V.
- 当前专利权人： Pamgene B.V.
- 当前专利权人地址： NL 's-Hertogenbosch
- 代理机构： Amster, Rothstein & Ebenstein LLP
- 优先权： EP09157816 20090410
- 国际申请： PCT/EP2010/054763 WO 20100412
- 国际公布： WO2010/115997 WO 20101014
- 主分类号： G01N33/00
- IPC分类号： G01N33/00 ; C12Q1/48 ; G01N33/574 ; G01N33/48 ; C40B30/06 ; C40B30/08
摘要：
The present invention relates to a method for determining the survival prognosis of patients suffering from non-small cell lung cancer. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels in response to a kinase inhibitor and profiles in samples obtained from patients diagnosed with non-small cell lung cancer. The present invention also provides methods for predicting the response of a patient diagnosed with non-small cell lung cancer to a medicament.
公开/授权文献
信息查询
